AU2001272932A1 - Angiostatin and endostatin binding proteins and methods of use - Google Patents

Angiostatin and endostatin binding proteins and methods of use

Info

Publication number
AU2001272932A1
AU2001272932A1 AU2001272932A AU7293201A AU2001272932A1 AU 2001272932 A1 AU2001272932 A1 AU 2001272932A1 AU 2001272932 A AU2001272932 A AU 2001272932A AU 7293201 A AU7293201 A AU 7293201A AU 2001272932 A1 AU2001272932 A1 AU 2001272932A1
Authority
AU
Australia
Prior art keywords
angiostatin
methods
binding proteins
endostatin binding
endostatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272932A
Other languages
English (en)
Inventor
Nicholas J. Macdonald
Kim Lee Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Casi Pharmaceuticals Inc
Original Assignee
Entremed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entremed Inc filed Critical Entremed Inc
Publication of AU2001272932A1 publication Critical patent/AU2001272932A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716Muscle proteins, e.g. myosin, actin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001272932A 2000-06-02 2001-06-04 Angiostatin and endostatin binding proteins and methods of use Abandoned AU2001272932A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20906500P 2000-06-02 2000-06-02
US60/209,065 2000-06-02
US28938701P 2001-05-08 2001-05-08
US60/289,387 2001-05-08
PCT/US2001/017947 WO2001093897A2 (fr) 2000-06-02 2001-06-04 Proteines de liaison de l'angiostatine et de l'endostatine et procedes d'utilisation

Publications (1)

Publication Number Publication Date
AU2001272932A1 true AU2001272932A1 (en) 2001-12-17

Family

ID=26903782

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272932A Abandoned AU2001272932A1 (en) 2000-06-02 2001-06-04 Angiostatin and endostatin binding proteins and methods of use

Country Status (3)

Country Link
US (1) US20020077289A1 (fr)
AU (1) AU2001272932A1 (fr)
WO (1) WO2001093897A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
AU2003218194A1 (en) * 2002-03-15 2003-09-29 Attenuon, Llc Cell surface tropomyosin as a target of angiogenesis inhibition
US7786278B2 (en) 2002-04-09 2010-08-31 Sanofi Pasteur Limited Modified CEA nucleic acid and expression vectors
DE60332122D1 (de) * 2002-08-28 2010-05-27 Novartis Ag Gentherapie des auges
WO2006058375A1 (fr) * 2004-12-01 2006-06-08 The Royal Alexandra Hospital For Children Identification de composes pour le traitement de maladies proliferatives
WO2013022991A2 (fr) 2011-08-08 2013-02-14 Curelab Oncology, Inc. Méthodes et compositions associées à p62 pour le traitement et la prophylaxie du cancer
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
CN107865824B (zh) * 2016-09-28 2020-04-03 山东先声生物制药有限公司 一种稳定的重组人血管内皮抑制素皮下注射组合物
WO2022003568A1 (fr) 2020-06-30 2022-01-06 Dcprime B.V. Utilisation de cellules dérivées de la leucémie dans des vaccins contre le cancer de l'ovaire
EP4281102A1 (fr) 2021-01-22 2023-11-29 Mendus B.V. Procédés de vaccination antitumorale
CA3212351A1 (fr) 2021-03-12 2022-09-15 Mendus B.V. Methodes de vaccination et utilisation d'un blocage de cd47

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201104B1 (en) * 1998-12-04 2001-03-13 Entremed, Inc. Angiogenesis—inhibiting protein binding peptides and proteins and methods of use

Also Published As

Publication number Publication date
WO2001093897A2 (fr) 2001-12-13
WO2001093897A3 (fr) 2002-10-31
US20020077289A1 (en) 2002-06-20
WO2001093897A9 (fr) 2003-02-06

Similar Documents

Publication Publication Date Title
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU3633000A (en) Neutrokine-alpha binding proteins and methods based thereon
IL153970A0 (en) Promyostatin peptides and methods of using same
AU2001288301A1 (en) Binding polypeptides and methods based thereon
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2001272932A1 (en) Angiostatin and endostatin binding proteins and methods of use
AU2002365202A1 (en) Synthetic genes for malarial proteins and methods of use
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
AU2001274566A1 (en) Novel protein and dna thereof
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002224403A1 (en) Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
AU2001264934A1 (en) Dna repair polypeptides and methods of use
AU2001284651A1 (en) Secreted proteins and methods of using same
AU2002256556A1 (en) Sea-trosy and related methods
AU2001292468A1 (en) Methods and means of rna analysis
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2002248697A1 (en) Novel rgs9 protein binding interactions and methods of use thereof
AU2002214598A1 (en) Claspin proteins and methods of use thereof
AU2000259049A1 (en) Histidyl-proline diketopiperazine and method of use
AU2002240921A1 (en) Medane genes and proteins
AU2001274563A1 (en) Novel polypeptide and its dna
AU2001271579A1 (en) Progesterone receptor-regulated gene expression and methods related thereto
AU2002227289A1 (en) Braf35 protein and brca2/braf35 complex and methods of use